跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
Bayesian cost-effectiveness analysis for censored data: An application to antiplatelet therapy
David Bin Chia Wu,
Yi Wen Tsai
, Yu Wen Wen
*
*
此作品的通信作者
衛生福利研究所
研究成果
:
Article
›
同行評審
5
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Bayesian cost-effectiveness analysis for censored data: An application to antiplatelet therapy」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Cost-effectiveness Analysis
100%
Censored Data
100%
Antiplatelet Therapy
100%
Bayesian Cost
100%
Aspirin
28%
Regression Model
28%
Clopidogrel
28%
Gastrointestinal Complications
28%
Proton Pump Inhibitors
28%
Cost-effectiveness
14%
Cardiovascular Risk Management
14%
Rehospitalization
14%
Normality Assumption
14%
High Risk
14%
Willingness to Pay
14%
Regression-based Method
14%
Bayesian Approach
14%
Posterior Distribution
14%
Hospitalization
14%
Regression Coefficient
14%
Covariate Adjustment
14%
Normality
14%
Bivariate Normal
14%
Censored Observations
14%
Drug Expenditure
14%
Markov Chain Monte Carlo Methods
14%
Bivariate Regression
14%
Gastrointestinal Bleeding
14%
Patient-level
14%
Cost-effectiveness Acceptability Curves
14%
Pharmacoeconomics
14%
Total Drug
14%
Time-to-event
14%
Normal Regression
14%
Mathematics
Bayesian
100%
Censored Data
100%
Regression Model
100%
Bivariate
66%
Covariate
33%
Bayesian Approach
33%
Posterior Distribution
33%
Markov Chain Monte Carlo Method
33%
Random Sample
33%
Censored Observation
33%
Regression Coefficient
33%
Economics, Econometrics and Finance
Bayesian
100%
Censored Data
100%
Cost-Effectiveness Analysis
100%
Willingness to Pay
14%
Monte Carlo Simulation
14%
Markov Chain Monte Carlo
14%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Censored Data
100%
Clopidogrel
22%
Proton Pump Inhibitor
22%
Hospital Readmission
11%
Cardiovascular Disease
11%
Sample Size
11%
Monte Carlo Method
11%
Pharmacoeconomics
11%
Drug Cost
11%
Gastrointestinal Hemorrhage
11%
Social Sciences
Cost-Effectiveness Analysis
100%
Censored Data
100%
Willingness-to-Pay
11%
Random Sample
11%
Markov Chain Monte Carlo
11%
Legal Procedure
11%
Cardiovascular Disease
11%
Psychology
Regression Model
100%
Monte Carlo Markov Chain Method
33%